Article Details
Retrieved on: 2021-08-05 16:12:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
At the time, Roche paid Vividion $135 million upfront. Vividion is eligible for up to “several billion dollars in payments” related to more preclinical, ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here